FDA Import Refusal 1FX-1905741-3/20002/5 — Cipla Limited

Cipla Limited — FEI 3007021905

The FDA refused shipment 1FX-1905741-3/20002/5 from Cipla Limited (India) on June 26, 2026. The refused product falls under Drugs and Biologics — MONTELUKAST SODIUM (ANTI-ASTHMATIC). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
June 26, 2026
Country
India
Product Category
Drugs and Biologics
Product Code
61EDA09 MONTELUKAST SODIUM (ANTI-ASTHMATIC)
Charges
75